Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.Tracy A. Brooks, Iwao Ojima, Paula Pera et al.|PubMed|2003Cited by 118
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023Hans Minderman, Maria R. Baer, Kieran L. O’Loughlin et al.|Cancer Chemotherapy and Pharmacology|2004Cited by 51
Design, Synthesis and Structure−Activity Relationships of Novel Taxane-Based Multidrug Resistance Reversal AgentsIwao Ojima, Ralph J. Bernacki, Christopher P. Borella et al.|Journal of Medicinal Chemistry|2005Cited by 35
Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.Tracy A. Brooks, Ralph J. Bernacki, Daniel R. Kennedy et al.|PubMed|2004Cited by 25
Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.C. I. HONG, Charles R. West, S.W. Hui et al.|PubMed|1990Cited by 8